Colin Dwyer
Colin Dwyer covers breaking news for NPR. He reports on a wide array of subjects — from politics in Latin America and the Middle East, to the latest developments in sports and scientific research.
Colin began his work with NPR on the Arts Desk, where he reviewed books and produced stories on arts and culture, then went on to write a daily roundup of news in literature and the publishing industry for the Two-Way blog — named Book News, naturally.
Later, as a producer for the Digital News desk, he wrote and edited feature news coverage, curated NPR's home page and managed its social media accounts. During his time on the desk, he co-created NPR's live headline contest "Head to Head," with Camila Domonoske, and won the American Copy Editors Society's annual headline-writing prize in 2015.
These days, as a reporter for the News Desk, he writes for NPR.org, reports for the network's on-air newsmagazines, and regularly hosts NPR's daily Facebook Live segment, "Newstime." He has covered hurricanes, international elections and unfortunate marathon mishaps, among many other stories. He also had some things to say about shoes once on Invisibilia.
Colin graduated from Georgetown University with a master's degree in English literature.
-
This week's new releases include a memoir from Amanda Knox reflecting on her murder case and exoneration, a biography of Yoko Ono, new fiction from Column McCann, and the latest Wicked book Elphie. -
This week brings a number of promising new reads — but none more eagerly awaited than Sunrise on the Reaping. We offer 5 books to consider picking up. -
Care and Feeding chronicles life in the culinary world. All the Other Mothers Hate Me follows a mom turned amateur detective. Plus, Karen Russell's first full-length novel since Swamplandia! -
The scathing report alleged that the FAA retaliated against whistleblowers, and said Boeing officials improperly influenced the outcome of tests of the aircraft's faulty flight control system. -
A day after the secretary of state became the highest-ranking administration official to blame Russia for a vast hack of multiple U.S. agencies, the president suggested someone else may be to blame. -
The Food and Drug Administration greenlights the biotech firm's vaccine for emergency use in the U.S. The move bolsters a vast inoculation effort that's already underway. -
In a survey by the Kaiser Family Foundation, 71% of respondents said they would definitely or probably get inoculated — a significant leap over the 63% who said so in an August/September poll. -
Army Gen. Gustave Perna told reporters that distribution of the vaccine from Pfizer and BioNTech has begun, with shipment to 636 sites scheduled to begin on Monday. -
The president vowed to "fight on" after the nation's highest court tossed a Texas lawsuit challenging the election results. The reaction from his congressional allies, however, was much more subdued. -
Pfizer and BioNTech's vaccine is the first to receive an emergency authorization from the Food and Drug Administration. Officials say it may be ready for widespread inoculations within days.
